457 related articles for article (PubMed ID: 17547568)
61. Investigating transfusion-related acute lung injury (TRALI).
Fung YL; Goodison KA; Wong JK; Minchinton RM
Intern Med J; 2003 Jul; 33(7):286-90. PubMed ID: 12823673
[TBL] [Abstract][Full Text] [Related]
62. Transfusion-related acute lung injury: a life-threatening transfusion reaction.
Tsalis K; Ganidou M; Blouhos K; Vasiliadis K; Betsis D
Med Sci Monit; 2005 May; 11(5):CS19-22. PubMed ID: 15874891
[TBL] [Abstract][Full Text] [Related]
63. Patient-specific transfusion-related acute lung injury.
Muniz M; Sheldon S; Schuller RM; Young NS; Klein HG; Leitman SF; Stroncek DF
Vox Sang; 2008 Jan; 94(1):70-3. PubMed ID: 18171330
[TBL] [Abstract][Full Text] [Related]
64. Investigations into the role of anti-HLA class II antibodies in TRALI.
Kao GS; Wood IG; Dorfman DM; Milford EL; Benjamin RJ
Transfusion; 2003 Feb; 43(2):185-91. PubMed ID: 12559014
[TBL] [Abstract][Full Text] [Related]
65. Designing and testing a computer-based screening system for transfusion-related acute lung injury.
Finlay HE; Cassorla L; Feiner J; Toy P
Am J Clin Pathol; 2005 Oct; 124(4):601-9. PubMed ID: 16146824
[TBL] [Abstract][Full Text] [Related]
66. Cytophilic immunoglobulin G binding on neutrophils from a child with malignant osteopetrosis who developed fatal acute respiratory distress mimicking transfusion-related acute lung injury.
Madyastha PR; Jeter EK; Key LL
Am J Hematol; 1996 Nov; 53(3):196-200. PubMed ID: 8895692
[TBL] [Abstract][Full Text] [Related]
67. [Transfusion-related acute lung injury with anti-leukocyte antibodies identified both in patient's serum and in red cell concentrate].
Nishizawa M; Hirayama F; Matsuyama N; Tada K; Kaneko H; Watanabe M; Miura Y; Tsudo M
Rinsho Ketsueki; 2009 Jan; 50(1):16-22. PubMed ID: 19225224
[TBL] [Abstract][Full Text] [Related]
68. Interference with TRALI-causing anti-HLA DR alloantibody induction of human pulmonary microvascular endothelial cell injury by purified soluble HLA DR.
Nishimura M; Hashimoto S; Satake M; Okazaki H; Tadokoro K
Vox Sang; 2007 Jul; 93(1):78-82. PubMed ID: 17547569
[TBL] [Abstract][Full Text] [Related]
69. Transfusion-related acute lung injury: a thrombotic thrombocytopenic purpura treatment-associated case report and concise review.
Cruz J; Skipworth E; Blue D; Waxman D; McCarthy L; Smith D
J Clin Apher; 2008; 23(2):96-103. PubMed ID: 18306280
[TBL] [Abstract][Full Text] [Related]
70. Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent.
Berger-Achituv S; Ellis MH; Curtis BR; Wolach B
Am J Hematol; 2008 Aug; 83(8):676-8. PubMed ID: 18383320
[TBL] [Abstract][Full Text] [Related]
71. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study.
Silliman CC; Paterson AJ; Dickey WO; Stroneck DF; Popovsky MA; Caldwell SA; Ambruso DR
Transfusion; 1997 Jul; 37(7):719-26. PubMed ID: 9225936
[TBL] [Abstract][Full Text] [Related]
72. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
Valeri CR; Ragno G
Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
[TBL] [Abstract][Full Text] [Related]
73. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
Vlaar AP; Wortel K; Binnekade JM; van Oers MH; Beckers E; Gajic O; Schultz MJ; Juffermans NP
Transfusion; 2010 Feb; 50(2):443-51. PubMed ID: 19804567
[TBL] [Abstract][Full Text] [Related]
74. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
75. Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations.
Swanson K; Dwyre DM; Krochmal J; Raife TJ
Lung; 2006; 184(3):177-85. PubMed ID: 16902843
[TBL] [Abstract][Full Text] [Related]
76. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
Flesch BK; Petershofen EK; Bux J
Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
[TBL] [Abstract][Full Text] [Related]
77. Transfusion-related acute lung injury: past, present, and future.
Cherry T; Steciuk M; Reddy VV; Marques MB
Am J Clin Pathol; 2008 Feb; 129(2):287-97. PubMed ID: 18208810
[TBL] [Abstract][Full Text] [Related]
78. A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura.
P'ng SS; Hughes AS; Cooney JP
Ther Apher Dial; 2008 Feb; 12(1):78-81. PubMed ID: 18257817
[TBL] [Abstract][Full Text] [Related]
79. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy.
Eder AF; Dy BA; Perez JM; Rambaud M; Benjamin RJ
Transfusion; 2013 Jul; 53(7):1442-9. PubMed ID: 23113676
[TBL] [Abstract][Full Text] [Related]
80. Transfusion-related acute lung injury (TRALI) in an obstetric patient.
Michala L; Madhavan B; Win N; De Lord C; Brown R
Int J Obstet Anesth; 2008 Jan; 17(1):66-9. PubMed ID: 18162202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
